Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LGR5 is a G protein-coupled receptor that functions as a stem cell marker in various tissues, particularly the intestinal epithelium and hair follicles. It potentiates Wnt signaling upon binding R-spondins and is frequently overexpressed in colorectal cancer, making it a target for cancer therapies.
Monoclonal antibodies or CAR-T approaches targeting LGR5
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5).